• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局限性硬皮病的诊断标准、严重程度分类及治疗指南。

Diagnostic criteria, severity classification and guidelines of localized scleroderma.

机构信息

Department of Dermatology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.

Department of Dermatology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.

出版信息

J Dermatol. 2018 Jul;45(7):755-780. doi: 10.1111/1346-8138.14161. Epub 2018 Apr 23.

DOI:10.1111/1346-8138.14161
PMID:29687475
Abstract

We established diagnostic criteria and severity classification of localized scleroderma because there is no established diagnostic criteria or widely accepted severity classification of the disease. Also, there has been no clinical guideline for localized scleroderma, so we established its clinical guideline ahead of all over the world. In particular, the clinical guideline was established by clinical questions based on evidence-based medicine according to the New Minds Clinical Practice Guideline Creation Manual (version 1.0). We aimed to make the guideline easy to use and reliable based on the newest evidence, and to present guidance as specific as possible for various clinical problems in treatment of localized scleroderma.

摘要

我们制定了局限性硬皮病的诊断标准和严重程度分类,因为目前还没有确立的诊断标准或广泛接受的疾病严重程度分类。此外,局限性硬皮病也没有临床指南,因此我们在全世界率先制定了其临床指南。特别是,该临床指南是根据循证医学基于新思维临床实践指南制定手册(第 1.0 版)的临床问题制定的。我们旨在根据最新的证据使该指南易于使用和可靠,并为局限性硬皮病的各种临床问题提供尽可能具体的指导。

相似文献

1
Diagnostic criteria, severity classification and guidelines of localized scleroderma.局限性硬皮病的诊断标准、严重程度分类及治疗指南。
J Dermatol. 2018 Jul;45(7):755-780. doi: 10.1111/1346-8138.14161. Epub 2018 Apr 23.
2
Diagnostic criteria, severity classification and guidelines of eosinophilic fasciitis.嗜酸性筋膜炎的诊断标准、严重程度分类和治疗指南。
J Dermatol. 2018 Aug;45(8):881-890. doi: 10.1111/1346-8138.14160. Epub 2017 Dec 13.
3
Diagnostic criteria, severity classification and guidelines of systemic sclerosis.系统性硬化症的诊断标准、严重程度分类和治疗指南。
J Dermatol. 2018 Jun;45(6):633-691. doi: 10.1111/1346-8138.14162. Epub 2018 Apr 23.
4
Diagnostic criteria, severity classification and guidelines of lichen sclerosus et atrophicus.硬化性苔藓型和萎缩型苔藓的诊断标准、严重程度分类和指南。
J Dermatol. 2018 Aug;45(8):891-897. doi: 10.1111/1346-8138.14171. Epub 2017 Dec 19.
5
German guidelines for the diagnosis and therapy of localized scleroderma.德国局限性硬皮病诊断与治疗指南。
J Dtsch Dermatol Ges. 2016 Feb;14(2):199-216. doi: 10.1111/ddg.12724.
6
Localized scleroderma.局限性硬皮病。
Dermatol Ther. 2012 Mar-Apr;25(2):135-47. doi: 10.1111/j.1529-8019.2012.01479.x.
7
European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes.欧洲皮肤病论坛 S1 指南:皮肤硬化病的诊断和治疗,第 1 部分:局限性硬皮病、系统性硬皮病和重叠综合征。
J Eur Acad Dermatol Venereol. 2017 Sep;31(9):1401-1424. doi: 10.1111/jdv.14458. Epub 2017 Aug 9.
8
Morphea and localized scleroderma in children.儿童硬斑病和局限性硬皮病
Semin Cutan Med Surg. 1999 Sep;18(3):210-25. doi: 10.1016/s1085-5629(99)80019-4.
9
[AWMF Guideline no. 013/066. Diagnosis and therapy of circumscribed scleroderma].[德国医学科学院指南第013/066号。局限性硬皮病的诊断与治疗]
J Dtsch Dermatol Ges. 2009 Sep;7 Suppl 6:S1-14. doi: 10.1111/j.1610-0387.2009.07178.x.
10
[How I explore ... the skin functional involvement in scleroderma].[我如何探究……硬皮病中皮肤的功能受累情况]
Rev Med Liege. 2013 Mar;68(3):141-7.

引用本文的文献

1
Markers of Type 2 Inflammation and Immunosenescence Are Upregulated in Localized Scleroderma.2型炎症和免疫衰老标志物在局限性硬皮病中上调。
Int J Mol Sci. 2025 Jan 31;26(3):1258. doi: 10.3390/ijms26031258.
2
The Serological Evidence of Positive Rheumatoid Factor in Morphea Patients and Its Relation to Disease Severity.硬斑病患者类风湿因子阳性的血清学证据及其与疾病严重程度的关系。
Cureus. 2024 May 26;16(5):e61105. doi: 10.7759/cureus.61105. eCollection 2024 May.
3
Prior elicitation of the efficacy and tolerability of Methotrexate and Mycophenolate Mofetil in Juvenile Localised Scleroderma.
甲氨蝶呤和霉酚酸酯在青少年局限性硬皮病中的疗效和耐受性的预先诱导。
AMRC Open Res. 2021 Sep 9;3:20. doi: 10.12688/amrcopenres.13008.1. eCollection 2021.
4
Immunological Profiles in Parry-Romberg Syndrome: A Case-Control Study.帕里-龙贝格综合征的免疫特征:一项病例对照研究。
J Clin Med. 2024 Feb 21;13(5):1219. doi: 10.3390/jcm13051219.
5
Biomarkers in skin autoimmunity-An update on localised scleroderma.皮肤自身免疫中的生物标志物——局限性硬皮病的最新进展
Skin Health Dis. 2024 Jan 12;4(2):e335. doi: 10.1002/ski2.335. eCollection 2024 Apr.
6
Nodular and diffuse spindle cell infiltration in keloidal scleroderma: a case report.瘢痕疙瘩性硬皮病中的结节性和弥漫性梭形细胞浸润:一例报告
Front Med (Lausanne). 2023 Dec 18;10:1291941. doi: 10.3389/fmed.2023.1291941. eCollection 2023.
7
Disturbances of the stomatognathic system and possibilities of its correction in patients with craniofacial morphea.颅面硬斑病患者口颌系统紊乱及其矫正可能性
Postepy Dermatol Alergol. 2023 Oct;40(5):592-598. doi: 10.5114/ada.2023.131865. Epub 2023 Nov 9.
8
Eosinophilic Fasciitis: Current and Remaining Challenges.嗜酸性筋膜炎:现状与遗留挑战。
Int J Mol Sci. 2023 Jan 19;24(3):1982. doi: 10.3390/ijms24031982.
9
Why, how, and when to use color Doppler ultrasound for improving precision in the diagnosis, assessment of severity and activity in morphea.为什么、如何以及何时使用彩色多普勒超声来提高硬斑病诊断的准确性、严重程度评估及活动度评估。
J Scleroderma Relat Disord. 2019 Feb;4(1):28-34. doi: 10.1177/2397198318799244. Epub 2018 Sep 24.
10
Clinical and laboratory characterization of patients with localized scleroderma and response to UVA-1 phototherapy: In vivo and in vitro skin models.局限性硬皮病患者的临床和实验室特征及 UVA-1 光疗的反应:体内和体外皮肤模型。
Photodermatol Photoimmunol Photomed. 2022 Nov;38(6):531-540. doi: 10.1111/phpp.12786. Epub 2022 Apr 3.